What are key innovation questions for the field of predictive toxicology? I propose we discuss the following questions at our Knowledge Cafe at the #OpenTox 2011 meeting in Munich. We can use the discussions as a basis to formulate an innovation white paper to provide direction to innovators who can accelerate developments in the field with strategy and technology development.
A. Mechanistic Strategies - What are the key innovations needed to accelerate progress?
B. Predictive Metabolism - What is needed for a complete and reliable prediction of metabolites?
C. Computational Chemistry - Emerging challenges and opportunities in receptor-mediated predictive toxicology
D. Systems Biology - How can we bridge the divide between modelling molecular pathways and quantitative prediction at the organelle level?
E. Integrated Analysis - Experimental designs for optimising biomarker discovery
F. Kinetics - Extrapolating in vitro data to model human hazard and exposure
G. Weight of Evidence - Developing holistic approaches to compound profiling and prioritisation-based decision making
H. Read Across and Categories - What are the key components for a more rigorous approach to a best practice?
I. Regulatory Needs - How do we accelerate the acceptance of emerging scientific methods in regulatory applications?
J. High Content Assays - What information can they provide today and what are the key gaps requiring new innovation?
Comments